Ascent Group’s Bausch Health BHC Stock Holding History

Ascent Group’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,560	Closed	-$94.8K	–	811
2026 Q1	$94.8K	Buy	+17,560	New	+$105K	﹤0.01%	747

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ascent Group's BHC Position: Q2 2026 in Review

Ascent Group sold out of Bausch Health (BHC) in Q2 2026, closing a stake of 17,560 shares — an estimated $94.8K sold.

Ascent Group first reported a position in BHC in Q1 2026 and held it in 1 quarter. The position peaked at $94.8K in Q1 2026. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

Ascent Group reported no remaining Bausch Health position as of Q2 2026 after selling out during the quarter.
Ascent Group sold 17,560 Bausch Health shares in Q2 2026, an estimated $94.8K.
Ascent Group first reported a position in Bausch Health in Q1 2026 and held it in 1 quarter.
Ascent Group's Bausch Health position peaked at $94.8K in Q1 2026.
222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.